meclofenamic acid has been researched along with diclofenac in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.76) | 18.7374 |
| 1990's | 8 (38.10) | 18.2507 |
| 2000's | 6 (28.57) | 29.6817 |
| 2010's | 5 (23.81) | 24.3611 |
| 2020's | 1 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Chalmers, DK; Craik, DJ; Iskander, MN; Kolliniatis, E; Munro, SL; Scholz, GH; Stockigt, JR; Topliss, DJ | 1 |
| Apiwattanakul, N; Chairoungdua, A; Endou, H; Kanai, Y; Nakajima, N; Sekine, T; Sophasan, S | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Chuang, S; Horne, J; Porter, CJ; Scanlon, MJ; Velkov, T | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Anan, I; Begum, A; Brännström, K; Gharibyan, AL; Iakovleva, I; Nilsson, L; Olofsson, A; Sauer-Eriksson, AE; Walfridsson, M | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bellamy, N; Buchanan, WW; Campbell, J; Gerecz-Simon, E; Kean, WF | 1 |
| Pellegrini, P | 1 |
| Blomgren, H; Hammarström, S; Petrini, B; Rotstein, S; Wasserman, J | 1 |
| Hamblin, PS; Kolliniatis, E; Lim, CF; Stockigt, JR; Topliss, DJ | 1 |
| Bowerbank, P; Noakes, TD; Reynolds, JF; Schwellnus, MP; Windt, A | 1 |
| Peplow, PV | 1 |
| Crabtree, JE; Davies, GR; Hull, MA; Jones-Blackett, S | 1 |
| Lozano, JJ; Pouplana, R; Ruiz, J | 1 |
| Attali, B; Degani, N; Gibor, G; Nachman, R; Peretz, A; Shabat, D; Uziyel, Y | 1 |
| Foster, GD; Thomas, PM | 1 |
| Attali, B; Danieli, E; Degani-Katzav, N; Gopin, A; Malka, E; Nachman, R; Peretz, A; Raz, A; Shabat, D; Talmon, M | 1 |
| Maskaoui, K; Zhou, JL | 1 |
| Griffiths, PC; Melia, CD; Pygall, SR; Timmins, P; Wolf, B | 1 |
| Ikushiro, S; Iwai, Y; Nishikawa, M; Sakaki, T; Sugimoto, H; Takita, T; Yasuda, K; Yasukawa, K; Yogo, Y | 1 |
1 review(s) available for meclofenamic acid and diclofenac
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for meclofenamic acid and diclofenac
| Article | Year |
|---|---|
Double blind randomized controlled trial of sodium meclofenamate (Meclomen) and diclofenac sodium (Voltaren): post validation reapplication of the WOMAC Osteoarthritis Index.
Topics: Adult; Diclofenac; Double-Blind Method; Female; Humans; Male; Meclofenamic Acid; Middle Aged; Osteoarthritis; Severity of Illness Index | 1992 |
Non-steroidal anti-inflammatory drugs fail to enhance healing of acute hamstring injuries treated with physiotherapy.
Topics: Adult; Athletic Injuries; Combined Modality Therapy; Diclofenac; Double-Blind Method; Female; Humans; Male; Meclofenamic Acid; Muscle, Skeletal; Physical Therapy Modalities | 1995 |
18 other study(ies) available for meclofenamic acid and diclofenac
| Article | Year |
|---|---|
Thyroid hormone uptake by hepatocytes: structure-activity relationships of phenylanthranilic acids with inhibitory activity.
Topics: Animals; Chemical Phenomena; Chemistry, Physical; Flufenamic Acid; Liver; Liver Neoplasms, Experimental; Meclofenamic Acid; Mefenamic Acid; Molecular Structure; ortho-Aminobenzoates; Rats; Structure-Activity Relationship; Triiodothyronine; Tumor Cells, Cultured | 1993 |
Transport properties of nonsteroidal anti-inflammatory drugs by organic anion transporter 1 expressed in Xenopus laevis oocytes.
Topics: Animals; Anion Transport Proteins; Anti-Inflammatory Agents, Non-Steroidal; Biological Transport; Carrier Proteins; Oocytes; Xenopus laevis | 1999 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Characterization of the drug binding specificity of rat liver fatty acid binding protein.
Topics: Anilino Naphthalenesulfonates; Animals; Fatty Acid-Binding Proteins; Ligands; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Protein Binding; Rats; Spectrometry, Fluorescence; Substrate Specificity | 2008 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Enthalpic Forces Correlate with the Selectivity of Transthyretin-Stabilizing Ligands in Human Plasma.
Topics: Amyloidosis; Calorimetry; Drug Design; Humans; Ligands; Models, Molecular; Plasma; Prealbumin; Protein Binding; Thermodynamics; X-Ray Diffraction | 2015 |
Clinical experiences in the treatment of pain in rheumatology.
Topics: Adult; Aged; Diclofenac; Female; Humans; Indomethacin; Male; Meclofenamic Acid; Middle Aged; Oxyphenbutazone; Pain; Rheumatic Diseases | 1991 |
In vitro capacity of various cyclooxygenase inhibitors to revert immune suppression caused by radiation therapy for breast cancer.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Breast Neoplasms; Cyclooxygenase Inhibitors; Diclofenac; Female; Humans; Immune Tolerance; In Vitro Techniques; Indomethacin; Ketoprofen; Lymphocyte Activation; Lysine; Meclofenamic Acid; Middle Aged; Phytohemagglutinins | 1990 |
Furosemide, fenclofenac, diclofenac, mefenamic acid and meclofenamic acid inhibit specific T3 binding in isolated rat hepatic nuclei.
Topics: Amiodarone; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Nucleus; Diclofenac; Furosemide; In Vitro Techniques; Liver; Male; Meclofenamic Acid; Mefenamic Acid; Phenylacetates; Phenytoin; Rats; Rats, Inbred Strains; Receptors, Thyroid Hormone | 1988 |
Identification of two different rate-limiting mechanisms controlling the release of NSAIDs from silastic polymeric devices, and possible implications.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Delayed-Action Preparations; Diclofenac; Meclofenamic Acid; Silicone Elastomers; Silicones | 1993 |
Non-steroidal anti-inflammatory drugs inhibit Helicobacter pylori-induced human neutrophil reactive oxygen metabolite production in vitro.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Dose-Response Relationship, Drug; Helicobacter pylori; Humans; In Vitro Techniques; Luminescent Measurements; Lymphocyte Activation; Male; Meclofenamic Acid; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Reactive Oxygen Species; Time Factors; Xanthine Oxidase; Xanthines | 1999 |
Molecular modelling of the differential interaction between several non-steroidal anti-inflammatory drugs and human prostaglandin endoperoxide H synthase-2 (h-PGHS-2).
Topics: Anti-Inflammatory Agents, Non-Steroidal; Computer Graphics; Computer Simulation; Crystallography, X-Ray; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diclofenac; Energy Transfer; Flurbiprofen; Humans; Indomethacin; Isoenzymes; Ketoprofen; Meclofenamic Acid; Mefenamic Acid; Membrane Proteins; Models, Molecular; Naproxen; Nitrobenzenes; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Sulfonamides | 2002 |
Meclofenamic acid and diclofenac, novel templates of KCNQ2/Q3 potassium channel openers, depress cortical neuron activity and exhibit anticonvulsant properties.
Topics: Action Potentials; Animals; Anticonvulsants; Carbamates; Cerebral Cortex; CHO Cells; Cricetinae; Diclofenac; KCNQ2 Potassium Channel; KCNQ3 Potassium Channel; Meclofenamic Acid; Phenylenediamines; Potassium Channels, Voltage-Gated; Rats; Rats, Sprague-Dawley | 2005 |
Tracking acidic pharmaceuticals, caffeine, and triclosan through the wastewater treatment process.
Topics: Caffeine; Diclofenac; Ibuprofen; Ketoprofen; Meclofenamic Acid; Models, Chemical; Naproxen; Pharmaceutical Preparations; Triclosan; Waste Disposal, Fluid; Water Pollutants, Chemical | 2005 |
A tale of switched functions: from cyclooxygenase inhibition to M-channel modulation in new diphenylamine derivatives.
Topics: Animals; CHO Cells; Cricetinae; Cricetulus; Cyclooxygenase Inhibitors; Diclofenac; Diphenylamine; Meclofenamic Acid; Mice; Potassium Channels | 2007 |
Colloids as a sink for certain pharmaceuticals in the aquatic environment.
Topics: Carbamazepine; Colloids; Diclofenac; Environmental Restoration and Remediation; Fresh Water; Indomethacin; Meclofenamic Acid; Pharmaceutical Preparations; Phenethylamines; Propranolol; Sewage; Sulfamethoxazole; Tamoxifen; Thioridazine; Water Pollutants, Chemical | 2010 |
Solution interactions of diclofenac sodium and meclofenamic acid sodium with hydroxypropyl methylcellulose (HPMC).
Topics: Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Hypromellose Derivatives; Meclofenamic Acid; Methylcellulose; Pharmaceutical Solutions; Solubility; Specific Gravity; Surface Tension; Transition Temperature; Viscosity | 2011 |
Metabolism of non-steroidal anti-inflammatory drugs (NSAIDs) by Streptomyces griseolus CYP105A1 and its variants.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Bacterial Proteins; Cytochrome P-450 Enzyme System; Diclofenac; Flufenamic Acid; Humans; Ibuprofen; Meclofenamic Acid; Mefenamic Acid; Streptomyces | 2022 |